Latest News in the pharma Industry
All
.jpg)
Recipharm acquisition to make it a top 5 global CDMO?
6 Feb 2020
CEO says the acquisition of Consort Medical will help to create a leading advanced delivery systems company.
Read more
New Velesco Pharma clinical manufacturing facility begins operations
5 Feb 2020
The facility will triple the company’s cGMP clinical trial manufacturing capacity.
Read more
Colorcon starts No-Tox ink manufacturing at new UK facility
4 Feb 2020
The additional capacity will provide customers with shorter lead times and reduced transportation costs.
Read more
Hovione announces key patent grants for its large dose DPI
4 Feb 2020
TwinMax enabes delivery of doses up to 100 mg formulated as drug alone or engineered particles.
Read more
Vetter aligns development service laboratory portfolio under one roof
3 Feb 2020
Bundling of competencies optimizes workflow of customer projects.
Read more
Delpharm and the Famar Group announce the acquisition by Delpharm of 5 manufacturing sites in France, Canada and the Netherlands.
3 Feb 2020
Delpharm and the Famar Group are pleased to announce the acquisition by Delpharm of 5 manufacturing sites belonging to Famar, in France, Canada and the Netherlands. The transaction signed today covers the French sites located in Orléans (Loiret), ...
Read more
FDA approves only triple-combination tablet with Jardiance
31 Jan 2020
Trijardy XR is a once-daily therapy combining three well-established treatments in one pill.
Read more
Sai Life Sciences to recruit 300+ scientists for its upcoming research facility
31 Jan 2020
Sai Life Sciences has initiated the recruitment of 300+ scientists for its upcoming integrated Research & Technology (R&T) centre in Hyderabad, India. This will result in doubling the full-time equivalents (FTEs) in the areas of discovery chemist...
Read more
OCD drug candidate created by AI ready for clinical trials in record time
31 Jan 2020
A new drug candidate has been created by artificial intelligence (AI) for the very first time, with the exploratory research route to phase I clinical trials taking less than 12 months, considerably shorter than the typical four and a half years using ...
Read more
CDMO WuXi Biologics says drug supply unaffected by coronavirus
30 Jan 2020
Amid heightened global concern over the recent coronavirus outbreak, Chinese CDMO WuXi Biologics has sought to reassure customers and patients that its drug supply lines have been unaffected.
Read more
ALPLApharma – a new global provider of innovative pharmaceutical packaging
30 Jan 2020
ALPLApharma, a new brand of the global packaging specialist ALPLA Group, will introduce itself for the first time to industry professionals at the CPhI Worldwide exhibition.
Read more.jpg)
Inovio and Beijing Advaccine to advance vaccine against Coronavirus
30 Jan 2020
Agreement will facilitate clinical trial translations in China.
Read more